ACL Digital Acquires a US-based CRO, Symbiance, to Expand and Scale its Clinical Research Capabilities
The strategic acquisition of Symbiance strengthens ACL Digital's footprint in the Clinical research sector, offering AI-driven clinical research, CRO, and pharmacovigilance solutions, and its commitment to drive digital transformation for global pharmaceutical, biotech, and medical device companies. SANTA CLARA, Calif. and BANGALORE, India, Sept. 26, 2025 /PRNewswire/ -- ACL Digital, a global leader in digital product innovation and engineering services, has announced the acquisition of...
Read Full Article